We are encouraged by
the new use of these stem cells to rapidly identify new treatments,» says co-senior author Dr. Jeffrey Rothstein, Director of the Brain Science Institute and the Robert Packard Center for ALS research at Johns Hopkins University.
Not exact matches
Using the gene - editing tool CRISPR - Cas9 to turn off certain genes in a mouse zygote as well as other
new techniques to enrich the pluripotent
stem cells of a rat, the group managed to grow various rat organs (a pancreas, heart, and eyes) in a mouse embryo.
Our client @RevivifyBio one
of the leaders for
Stem Cell, Amniotic Tissue Regeneration and PRP launches
new campaign
using @nFuszInc
new Notify CRM 2.0 this week.
This includes a
stem cell research centre, a network
of drug discovery institutes and a # 20 million global clinical development fund dedicated to supporting Phase I and II clinical trials; and a # 2 million collaboration between University
of Cambridge and University College London that will
use donated
cells from people with Alzheimer's to test potential
new treatments
According to Science Daily, Dr. Nagy, senior investigator at the Samuel Lunenfeld Research Institute
of Mount Sinai Hospital, there is a «
new method
of generating
stem cells that does not require embryos as starting points and could be
used to generate
cells from many adult tissues such as a patient's own skin
cells.»
Adult
stem -
cells are now being
used to grow
new body - parts that can be implanted with no risk
of rejection, the latter being the single largest cause
of organ rejection and subsequent death.
Just before Thanksgiving, news broke about a
new stem -
cell technique that could produce the equivalent
of embryonic
stem cells (ESCs) but without
using or destroying human embryos.
The increasing
use of in - vitro - fertilisation techniques, and the emergence
of new possibilities involving human cloning, mixing
of human and animal genetic elements, and the
use of embryonic
stem cells for research, among other things, brought the need for further teaching.
They discovered that the chemicals and radiation
used to kill tumor
cells damage the
stem cell reservoir in the hippocampus and nearly halt the formation
of new neurons in both children and adults.
Working with Skeletal Biologists at Southampton General Hospital, Catarina is investigating
new optical techniques to monitor the development
of the
cells,
used in
new regenerative medicine approaches — in this case, to create and grow cartilage from human
stem cells.
Researchers at Rush University Medical Center are exploring a
new therapy
using stem cells to treat spinal cord injuries within the first 14 to 30 days
of injury.
Researchers, led by Joshua Mayourian at the Icahn School
of Medicine at Mount Sinai,
used mathematical modeling to simulate electrical interactions between these
stem cells and heart
cells to develop insight into possible adverse effects, as well as to hypothesize
new methods for reducing some potential risks
of this therapy.
Realistic
stem cell therapies to replace diseased or damaged tissue may still be years away, but researchers have uncovered a promising
new use for these undifferentiated
cells: they can be programmed to become patient - specific laboratory models
of inherited liver disease.
The
new rules state that
stem cells can be
used if they are part
of a study approved by the federal government, or if the protocol has been approved by an Institutional Review Board (IRB) that provides ethical review for research involving human volunteers.
Hamilton announced the
newest organ - on - chip innovation, which recreates an intestinal lining
using patient - derived
stem cells, created through a partnership between Emulate and Cedars - Sinai Board
of Governors Regenerative Medicine Institute.
Scientists at the UCLA Eli and Edythe Broad Center
of Regenerative Medicine and
Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a
new approach that could eventually be
used to treat Duchenne muscular dystrophy.
These include the ability to bring
new, innovative products to the market; progress in oncology, such as the approval
of Genentech's drug Avastin for breast cancer and advances in the
use of gene therapy, despite some setbacks; continuing progress in research on
stem cells; the emergence
of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.
The Champalimaud Center for Translation Eye Research (C - TRACER), part
of the LV Prasad Eye Institute in Hyderabad, India, will continue research begun by LV Prasad scientists, who
use eye
stem cells from living adults to grow
new cells that are then implanted into damaged eyes.
The continued marketing and
use of experimental
stem cell - based interventions inside and outside the United States is problematic and unsustainable, according to a
new paper by science policy and bioethics experts at Rice University's Baker Institute for Public Policy and Wake Forest University.
The distribution
of fluorescent daughter
cells can be
used to create a mathematical model
of blood formation, which can provide
new insights into the behavior
of stem cells.
The
new method, described in the journal
Stem Cells Translational Medicine, could be used to generate large numbers of muscle cells and muscle progenitors directly from human pluripotent stem ce
Stem Cells Translational Medicine, could be used to generate large numbers of muscle cells and muscle progenitors directly from human pluripotent stem c
Cells Translational Medicine, could be
used to generate large numbers
of muscle
cells and muscle progenitors directly from human pluripotent stem c
cells and muscle progenitors directly from human pluripotent
stem ce
stem cellscells.
«With the rise
of new and unproven
stem cell treatments, the NFL faces a daunting task
of trying to better understand and regulate the
use of these therapies in order to protect the health
of its players,» said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development.
The laboratory process, described in the journal Scientific Reports, entails genetically modifying a line
of human embryonic
stem cells to become fluorescent upon their differentiation to retinal ganglion
cells, and then
using that
cell line for development
of new differentiation methods and characterization
of the resulting
cells.
Using next - generation sequencing technologies that were previously unavailable, Michael Gardner, a graduate research assistant, and Jianying Wang, a senior research associate in Mitchum's lab, made a remarkable
new discovery — nematodes possess the ability to produce a second type
of peptide that can effectively «take over» plant
stem cells that are
used to create vital pathways for the delivery
of nutrients throughout the plant.
Whether mammals generate
new eggs in adulthood
using stem cells has been a source
of scientific controversy.
Antibiotics are cheap and readily available and if in time the link between their
use and the eradication
of cancer
stem cells can be proved, this work may be the first step towards a
new avenue for cancer treatment.
A therapeutic screening center, headed by Lee Rubin at the Harvard Department
of Stem Cell and Regenerative Biology, is dedicated to using induced pluripotent stem cells to find new drugs for genetic disea
Stem Cell and Regenerative Biology, is dedicated to
using induced pluripotent
stem cells to find new drugs for genetic disea
stem cells to find
new drugs for genetic diseases.
Last January, the House
of Representatives voted, 253 to 174, to pass a bill, H.R. 3, that would allow researchers to
use leftover embryos from in vitro fertilization (IVF) clinics to create
new lines
of embryonic
stem cells, and in April, the Senate passed its version
of the bill.
The study, which was led by postdoc Gregor Pilz and PhD student Sara Bottes,
used in vivo 2 - photon imaging and genetic labeling
of neural
stem cells in order to observe
stem cell divisions as they happened, and to follow the maturation
of new nerve
cells for up to two months.
Mindful
of public sensitivities, Daley opted to pursue experiments
using what he considers the least controversial human materials to create
new nonpresidential
stem cell lines — poor quality embryos and oocytes that, in his words, «otherwise would have been disposed
of as medical waste.»
But
stem cell biologist and physician Michele De Luca
of the University
of Modena and Reggio Emilia in Italy and his colleagues have been developing a way to counteract an EB - causing mutation by inserting a
new gene into the
cells used for grafts.
«LEVER 3 - D is amazing, it opens
new vistas for understanding the
stem cell niche,» said Dr. Sally Temple, a cell biologist at the Neural Stem Cell Institute in Rensselaer, N.Y. who has been using Cohen's software, through the course of its development, as part of her stem cell research since 2
stem cell niche,» said Dr. Sally Temple, a cell biologist at the Neural Stem Cell Institute in Rensselaer, N.Y. who has been using Cohen's software, through the course of its development, as part of her stem cell research since 2
cell niche,» said Dr. Sally Temple, a
cell biologist at the Neural Stem Cell Institute in Rensselaer, N.Y. who has been using Cohen's software, through the course of its development, as part of her stem cell research since 2
cell biologist at the Neural
Stem Cell Institute in Rensselaer, N.Y. who has been using Cohen's software, through the course of its development, as part of her stem cell research since 2
Stem Cell Institute in Rensselaer, N.Y. who has been using Cohen's software, through the course of its development, as part of her stem cell research since 2
Cell Institute in Rensselaer, N.Y. who has been
using Cohen's software, through the course
of its development, as part
of her
stem cell research since 2
stem cell research since 2
cell research since 2005.
«As researchers started
using these
cells more, it became clear that during the process
of reprogramming to create
stem cells the
cell was also rejuvenated in other ways,» says Jerome Mertens, a postdoctoral research fellow and first author
of the
new paper.
Results from a clinical trial investigating a
new T
cell receptor (TCR) therapy that
uses a person's own immune system to recognize and destroy cancer
cells demonstrated a clinical response in 80 percent
of multiple myeloma patients with advanced disease after undergoing autologous
stem cell transplants (ASCT).
The
new approach builds on information gleaned from developmental studies
of embryonic
stem cells (see story # 16) and one day may be
used to create healthy replacements for harmed or diseased tissue.
Applying a
new method that is
used mainly in
stem -
cell research and regenerative medicine, researchers from the Technical University
of Munich have now devised a robust intestinal model for molecular research into incretin release in a test tube (in vitro).
A
new study in mice published in The Journal
of Neuroscience details a potential therapeutic strategy that
uses stem cells to promote recovery
of motor activity after spinal cord injury.
A
new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life - threatening complication
of stem cell transplants (SCT)
used to treat leukemia and other blood disorders, according to a study led by researchers at the Icahn School
of Medicine at Mount Sinai and published online today in the journal Lancet Haematology and in print in the January issue.
Ultimately, the goal is to
use stem cells of an individual patient and create a personalized model
of their reproductive system to test
new drugs for safety and effectiveness.
«The induced pluripotent
stem cells we
used in this study proved to be extremely useful in disease modelling, and they could offer an excellent platform for drug discovery and testing
new therapeutic targets for Alzheimer's disease in the future,» says Early Stage Researcher Minna Oksanen, the lead author
of the study.
Lorenz Studer, a
stem -
cell biologist at the Memorial Sloan Kettering Cancer Center in
New York City who has spent years characterizing such neurons ahead
of his own planned clinical trials, says that «support is not very strong» for the
use of precursor
cells.
After two earlier published attempts that led to early - stage embryos but not confirmed embryonic
stem cells, Mitalipov and colleagues took steps to preserve a protein complex believed to help primate eggs restructure transplanted DNA, and employed a
new imaging system to observe the egg's chromosomes directly instead
of by staining them or
using ultraviolet light, which might damage DNA.
«This information yields
new insights into how sperm
stem cells function and develop under normal circumstances,» says the study's lead author Bradley Cairns, PhD, senior director
of basic science at HCI and professor and chair
of oncological sciences at the U
of U. «We have built a very important framework we can now
use to help us understand what happens when things go wrong, resulting in issues like infertility and cancer in men.»
So beginning in 2000, the University
of Minnesota began a
new approach:
using stem cells from two umbilical cord blood sources, which increased the chances
of engraftment in adults to 90 percent.
The achievement represents a
new direction in the
use of human pluripotent
stem cells, which have the potential to develop into any
of the tissues
of the human body.
Ploegh envisions the technique being
used to create a
new type
of personalized therapy in the future — your own
cells could be isolated,
used to create
stem cells that differentiate into erythroblasts, genetically modified to carry a molecule, and reinjected into your body.
Theoretically, such
stem cells can form any
of the body's
cell types and could be
used in
new treatments for Parkinson's disease, diabetes, multiple sclerosis, cardiac disease, and spinal cord injuries.
In a
new study scheduled for publication in The Journal
of Pediatrics, researchers evaluated the safety and feasibility
of using stem cell therapies on very preterm infants to prevent or treat BPD.
A particular type
of stem cell found in muscle can give rise to
new muscle tissue, so a team led by geneticist Luis Garcia
of Généthon, a nonprofit biotechnology firm in Évry, France, investigated whether these
cells could be
used to reverse the dystrophin problems.
With so much work needed in studying the nature
of stem cells and
using them to study disease processes, therapies based on ES
cells seem very far down the line, noted Lorenz Studer
of Memorial Sloan - Kettering Cancer Center in
New York, who pointed out that so far there have only been two published papers on therapeutic cloning, both
of them in mice.